• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk-based classification of hypertension and the role of combination therapy.基于风险的高血压分类及联合治疗的作用。
J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):4-12. doi: 10.1111/j.1524-6175.2007.08134.x.
2
[Recent intervention studies with antihypertensive drugs and their influence on guidelines].[近期抗高血压药物干预研究及其对指南的影响]
Med Klin (Munich). 2003 Dec 15;98(12):771-5. doi: 10.1007/s00063-003-1323-4.
3
Goals of antihypertensive therapy.抗高血压治疗的目标。
Drugs. 1995 Feb;49(2):161-75. doi: 10.2165/00003495-199549020-00002.
4
Treating hypertension with cardioprotective therapies: the role of ACE inhibitors, ARBs, and beta-blockers.使用心脏保护疗法治疗高血压:血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂和β受体阻滞剂的作用。
J Cardiovasc Nurs. 2005 Sep-Oct;20(5):354-64. doi: 10.1097/00005082-200509000-00010.
5
[Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].[钙拮抗剂:基于新证据的当前及未来应用。钙通道阻滞剂联合抗高血压治疗]
Clin Calcium. 2010 Jan;20(1):52-60.
6
[Combination drug therapy in hypertension].[高血压的联合药物治疗]
Nihon Rinsho. 2004 Mar;62 Suppl 3:596-602.
7
[Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].[高血压的分类与风险分层 欧洲高血压学会(ESH)建议]
MMW Fortschr Med. 2003 Nov 6;145(45):41-2.
8
Special considerations for antihypertensive agents in dialysis patients.透析患者的降压药物的特殊考虑因素。
Blood Purif. 2010;29(2):93-8. doi: 10.1159/000245631. Epub 2010 Jan 8.
9
Fixed-dose combination therapy in hypertension: pros.高血压的固定剂量联合治疗:优点
High Blood Press Cardiovasc Prev. 2012 Jun 1;19(2):55-7. doi: 10.1007/BF03262454.
10
Update on the management of hypertension: recent clinical trials and the JNC 7.高血压管理的最新进展:近期临床试验与美国国家联合委员会第7次报告
J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):4-13. doi: 10.1111/j.1524-6175.2004.03830.x.

引用本文的文献

1
A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone.阿齐沙坦美多昔酯联合氯噻酮疗效及安全性的随机试验
J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318795000. doi: 10.1177/1470320318795000.
2
Prognostic significance of the morning blood pressure surge in clinical practice: a systematic review.临床实践中清晨血压激增的预后意义:一项系统综述
Am J Hypertens. 2015 Jan;28(1):30-41. doi: 10.1093/ajh/hpu104. Epub 2014 Oct 14.
3
Angiotensin II Blockade and Total Cardiovascular Risk : Beyond Blood Pressure Reduction.血管紧张素II阻断与心血管总体风险:超越血压降低
High Blood Press Cardiovasc Prev. 2008 Oct;15(4):245-53. doi: 10.2165/0151642-200815040-00004. Epub 2013 Jan 22.
4
Appetite suppressants, cardiac valve disease and combination pharmacotherapy.食欲抑制剂、心脏瓣膜病与联合药物治疗
Am J Ther. 2009 Jul-Aug;16(4):354-64. doi: 10.1097/MJT.0b013e31817fde95.

本文引用的文献

1
The vasodilatory beta-blockers.血管舒张性β受体阻滞剂
Curr Hypertens Rep. 2007 Aug;9(4):269-77. doi: 10.1007/s11906-007-0050-2.
2
The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?为达到目标血压而进行联合抗高血压治疗的必要性:从临床实践和发病率-死亡率试验中学到了什么?
Int J Clin Pract. 2007 Sep;61(9):1592-602. doi: 10.1111/j.1742-1241.2007.01302.x.
3
Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.奈必洛尔通过诱导型一氧化氮合酶激活在心脏中诱导一氧化氮释放。
Hypertension. 2007 Oct;50(4):652-6. doi: 10.1161/HYPERTENSIONAHA.107.094458. Epub 2007 Jul 30.
4
Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.原发性高血压患者的大动脉和小动脉内皮功能——血管紧张素转换酶抑制和β受体阻滞剂的作用
Blood Press. 2007;16(2):106-13. doi: 10.1080/08037050701343688.
5
Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.双重钙通道及肾素-血管紧张素系统阻断对高血压血管疾病的靶向作用机制
J Hum Hypertens. 2007 Oct;21(10):770-9. doi: 10.1038/sj.jhh.1002254. Epub 2007 Jun 28.
6
Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.卡维地洛与美托洛尔对2型糖尿病患者内皮功能和氧化应激的影响
Am J Hypertens. 2007 Jul;20(7):777-83. doi: 10.1016/j.amjhyper.2007.01.019.
7
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2007年动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组制定。
Eur Heart J. 2007 Jun;28(12):1462-536. doi: 10.1093/eurheartj/ehm236. Epub 2007 Jun 11.
8
The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.与选择利尿剂或β受体阻滞剂相比,选择钙通道阻滞剂与新发2型糖尿病的发生有关。
Curr Med Res Opin. 2007 Jun;23(6):1239-44. doi: 10.1185/030079907X188044. Epub 2007 Apr 23.
9
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.“新型”与“传统”抗高血压药物对血液流变学、血小板及内皮因子的影响。盎格鲁-斯堪的纳维亚心脏结局试验的一项子研究。
Am J Hypertens. 2007 Jun;20(6):699-704. doi: 10.1016/j.amjhyper.2007.01.004.
10
Risk-factor clustering and cardiovascular disease risk in hypertensive patients.高血压患者的危险因素聚集与心血管疾病风险
Am J Hypertens. 2007 Jun;20(6):599-607. doi: 10.1016/j.amjhyper.2006.10.013.

基于风险的高血压分类及联合治疗的作用。

Risk-based classification of hypertension and the role of combination therapy.

作者信息

Weir Matthew R

机构信息

Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD 21202, USA.

出版信息

J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):4-12. doi: 10.1111/j.1524-6175.2007.08134.x.

DOI:10.1111/j.1524-6175.2007.08134.x
PMID:18174778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8109914/
Abstract

The recognition of a continuous relationship between elevated blood pressure (BP) and cardiovascular risk has influenced national and international guidelines for the classification, prevention, and management of hypertension. The most recent report (2003) of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure uses BP thresholds to define categories of normal, prehypertension, and hypertension. A new definition proposed by the Hypertension Writing Group in 2005 offers an approach to diagnosis and management based on global or total risk. Thus, even in the absence of sustained elevations in BP, patients may have a moderate to high risk of vascular events due to the presence of additional cardiovascular risk factors, disease markers, and target organ damage. The 2007 European guidelines continue to classify hypertension based on cutoffs while also placing emphasis on multivariate formulations for cardiovascular risk assessment and goals of therapy. All 3 sets of guidelines acknowledge the necessity of using > or =2 antihypertensive agents to attain BP goals in many patients.

摘要

血压(BP)升高与心血管风险之间持续关系的认识,影响了国内外关于高血压分类、预防和管理的指南。美国国家高血压预防、检测、评估与治疗联合委员会的最新报告(2003年)使用血压阈值来定义正常、高血压前期和高血压类别。高血压写作组在2005年提出的新定义提供了一种基于总体或全部风险的诊断和管理方法。因此,即使血压没有持续升高,由于存在其他心血管危险因素、疾病标志物和靶器官损害,患者也可能有中度至高风险的血管事件。2007年欧洲指南继续根据临界值对高血压进行分类,同时也强调用于心血管风险评估和治疗目标的多变量公式。所有这三套指南都承认,在许多患者中需要使用≥2种抗高血压药物来实现血压目标。